Its results for the first half of the year show that EBITDA rose to €505m (£392m) from €397m.
Like-for-like sales were up 5%, with sales revenue increasing by 7% in Europe and 1% in the Americas.
Incremental cost savings of €45m have been achieved to date in 2014, with the full-year target of €100m on track. There is also a continued focus on cash flow, with lower seasonal working capital and capital expenditure outflows.
CRH’s portfolio review is progressing, with a multi-year divestment programme of about €1.5bn to €2bn under way. In the first half, it also made acquisitions and investments of €130m.
The net debt was €3.7bn in June, €0.5bn than in June 2013.